Description
Fulvestrant is listed in the oncology-focused API portfolio. The page is a technical overview only; clinical, regulatory and commercial status must be established from approved product documentation.
← Back to all products
Oncology API / Pharmaceutical technical profile
Fulvestrant
(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
Category: Oncology APICAS No.: 129453-61-8Formula: C32H47F5O3S
Swati Industries portfolio01 02 03
Chemical & technical profile
Product nameFulvestrant
CategoryOncology API
CAS No.129453-61-8
Molecular formulaC32H47F5O3S
Molecular weight606.8 g/mol
PubChem CID104741
Research & Development
Impurity identification and fate mapping; genotoxic-impurity risk assessment where relevant; robust assay/related-substances methods; solid-state characterization; stability and packaging studies.
Analytical testing
Identity by IR/LC-MS/NMR; assay and related substances by HPLC/UPLC; residual solvents by GC; water content; XRPD/DSC and particle-size testing where specification-relevant.
Verified chemical reference
(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
Open PubChem reference ↗Technical overview only; not a validated manufacturing process or a claim of company capability. Confirm chemical form, CAS No., grade and specifications from the approved specification and batch COA.